Abstract
Background
Multiple sclerosis (MS) is associated with high prevalence of cognitive impairment, ranging from 40 to 80%. The purpose of this single-center retrospective study was to examine the relation between cognitive function, as measured by Symbol Digit Modalities Test (SDMT), with fatigue, anxiety, and depression symptoms in a Belgian cohort of patients with MS.
Methods
Sociodemographic and clinical data were analyzed in 66 (F:40, M:26) Belgian patients with a diagnosis of MS. The cognitive function was assessed with the oral version of SDMT, depression and anxiety symptoms with the Hospital Anxiety and Depression scale (HAD), fatigue symptoms with the French valid version of the Fatigue Impact Scale in MS (EMIF-SEP), which is a scale composed of four dimensions (cognitive, physical, social, and psychological) allowing a multidimensional evaluation of fatigue.
Results
The multivariate linear regression analysis demonstrated that lower SDMT scores were associated with higher EDSS score and psychological dimension of fatigue symptoms. No association were found between SDMT and anxiety or depression symptoms. Conversely, higher depression and anxiety symptoms were associated with higher total fatigue symptoms, but lower physical dimension of fatigue symptoms. Higher anxiety symptoms were also independently associated with higher social dimension of fatigue symptoms.
Conclusion
A complex relationship exists between cognitive performance, fatigue, and neuropsychiatric symptoms in Belgian people with MS. The level of disability and fatigue adversely affects the cognitive function in MS, whereas depression and anxiety seem to not have a significant effect. A more complex relationship exists between fatigue and neuropsychiatric symptoms, with a divergent interplay between the different dimensions of fatigue that supports the multidimensional approach to assessing fatigue in MS.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available on request from the corresponding author, SB. The data are not publicly available due to their containing information that could compromise the privacy of research participants.
References
Fischer M, Kunkel A, Bublak P, Faiss JH, Hoffmann F, Sailer M et al (2014) How reliable is the classification of cognitive impairment across different criteria in early and late stages of multiple sclerosis? J Neurol Sci 343(1–2):91–99
Calabrese P, Penner IK (2007) Cognitive dysfunctions in multiple sclerosis–a “multiple disconnection syndrome”? J Neurol 254(2):II18–II21
Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F (1991) Cognitive dysfunction in multiple sclerosis II Impact on employment and social functioning. Neurology 41(5):692–696
Langdon DW (2011) Cognition in multiple sclerosis. Curr Opin Neurol 24(3):244–249
Pitteri M, Romualdi C, Magliozzi R, Monaco S, Calabrese M (2017) Cognitive impairment predicts disability progression and cortical thinning in MS: an 8 year study. Mult Scler 23(6):848–854
Bobholz JA, Rao SM (2003) Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol 16(3):283–288
Benedict RH, Duquin JA, Jurgensen S, Rudick RA, Feitcher J, Munschauer FE et al (2008) Repeated assessment of neuropsychological deficits in multiple sclerosis using the symbol digit modalities test and the MS neuropsychological screening questionnaire. Mult Scler 14(7):940–946
Korostil M, Feinstein A (2007) Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler 13(1):67–72
Patten SB, Beck CA, Williams JV, Barbui C, Metz LM (2003) Major depression in multiple sclerosis: a population-based perspective. Neurology 61(11):1524–1527
Hermann BP, Vickrey B, Hays RD, Cramer J, Devinsky O, Meador K et al (1996) A comparison of health-related quality of life in patients with epilepsy, diabetes and multiple sclerosis. Epilepsy Res 25(2):113–118
Amato MP, Ponziani G, Rossi F, Liedl CL, Stefanile C, Rossi L (2001) Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult Scler 7(5):340–344
Arnett PA, Barwick FH, Beeney JE (2008) Depression in multiple sclerosis: review and theoretical proposal. J Int Neuropsychol Soc 14(5):691–724
Morrow SA, Rosehart H, Pantazopoulos K (2016) Anxiety and depressive symptoms are associated with worse performance on objective cognitive tests in MS. J Neuropsychiatry Clin Neurosci 28(2):118–123
Bakshi R, Shaikh ZA, Miletich RS, Czarnecki D, Dmochowski J, Henschel K et al (2000) Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler 6(3):181–185
Binzer S, McKay KA, Brenner P, Hillert J, Manouchehrinia A (2019) Disability worsening among persons with multiple sclerosis and depression: a Swedish cohort study. Neurology 93(24):e2216–e2223
Gill S, Santo J, Blair M, Morrow SA (2019) Depressive symptoms are associated with more negative functional outcomes than anxiety symptoms in persons with multiple sclerosis. J Neuropsychiatry Clin Neurosci 31(1):37–42
Siegert RJ, Abernethy DA (2005) Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry 76(4):469–475
Oreja-Guevara C, Ayuso Blanco T, Brieva Ruiz L, Hernandez Perez MA, Meca-Lallana V, Ramio-Torrenta L (2019) Cognitive dysfunctions and assessments in multiple sclerosis. Front Neurol 10:581
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162–173
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292–302
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370
Debouverie M, Pittion-Vouyovitch S, Louis S, Guillemin F (2007) Validity of a French version of the fatigue impact scale in multiple sclerosis. Mult Scler 13(8):1026–1032
Capet N, Joly H, Suply C, Mondot L, Cohen M, Lebrun-Frenay C (2021) Alexithymia in multiple sclerosis: clinical and radiological correlations. Rev Neurol (Paris) 177(3):302–311
Olsson I, Mykletun A, Dahl AA (2005) The hospital anxiety and depression rating scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry 5:46
Skorve E, Lundervold AJ, Torkildsen O, Myhr KM (2019) The Norwegian translation of the brief international cognitive assessment for multiple sclerosis (BICAMS). Mult Scler Relat Disord 36:101408
Vanotti S, Smerbeck A, Benedict RH, Caceres F (2016) A new assessment tool for patients with multiple sclerosis from Spanish-speaking countries: validation of the Brief international cognitive assessment for MS (BICAMS) in Argentina. Clin Neuropsychol 30(7):1023–1031
Giedraitiene N, Kizlaitiene R, Kaubrys G (2015) The BICAMS battery for assessment of lithuanian-speaking multiple sclerosis patients: relationship with age, education, disease disability, and duration. Med Sci Monit 21:3853–3859
Smerbeck A, Benedict RHB, Eshaghi A, Vanotti S, Spedo C, Blahova Dusankova J et al (2018) Influence of nationality on the brief international cognitive assessment for multiple sclerosis (BICAMS). Clin Neuropsychol 32(1):54–62
Strober LB, Bruce JM, Arnett PA, Alschuler KN, Lebkuecher A, Di Benedetto M et al (2020) A new look at an old test: normative data of the symbol digit modalities test-oral version. Mult Scler Relat Disord 43:102154
Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Goretti B et al (2009) Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the cognitive impairment in multiple sclerosis (COGIMUS) study. Mult Scler 15(7):779–788
Costa SL, DeLuca J, Sandroff BM, Goverover Y, Chiaravalloti ND (2018) Role of demographic and clinical factors in cognitive functioning of persons with relapsing-remitting and progressive multiple sclerosis. J Int Neuropsychol Soc 24(2):139–146
Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC (1988) Fatigue in multiple sclerosis. Arch Neurol 45(4):435–437
Yigit P, Acikgoz A, Mehdiyev Z, Dayi A, Ozakbas S (2021) The relationship between cognition, depression, fatigue, and disability in patients with multiple sclerosis. Ir J Med Sci 190(3):1129–1136
Schoonheim MM, Hulst HE, Landi D, Ciccarelli O, Roosendaal SD, Sanz-Arigita EJ et al (2012) Gender-related differences in functional connectivity in multiple sclerosis. Mult Scler 18(2):164–173
Kinsinger SW, Lattie E, Mohr DC (2010) Relationship between depression, fatigue, subjective cognitive impairment, and objective neuropsychological functioning in patients with multiple sclerosis. Neuropsychology 24(5):573–580
van der Hiele K, Spliethoff-Kamminga NG, Ruimschotel RP, Middelkoop HA, Visser LH (2012) The relationship between self-reported executive performance and psychological characteristics in multiple sclerosis. Eur J Neurol 19(4):562–569
Carone DA, Benedict RH, Munschauer FE 3rd, Fishman I, Weinstock-Guttman B (2005) Interpreting patient/informant discrepancies of reported cognitive symptoms in MS. J Int Neuropsychol Soc 11(5):574–583
Induruwa I, Constantinescu CS, Gran B (2012) Fatigue in multiple sclerosis–a brief review. J Neurol Sci 323(1–2):9–15
DeLuca J, Genova HM, Hillary FG, Wylie G (2008) Neural correlates of cognitive fatigue in multiple sclerosis using functional MRI. J Neurol Sci 270(1–2):28–39
Kaminska M, Kimoff RJ, Schwartzman K, Trojan DA (2011) Sleep disorders and fatigue in multiple sclerosis: evidence for association and interaction. J Neurol Sci 302(1–2):7–13
Tartaglia MC, Narayanan S, Francis SJ, Santos AC, De Stefano N, Lapierre Y et al (2004) The relationship between diffuse axonal damage and fatigue in multiple sclerosis. Arch Neurol 61(2):201–207
Ford H, Trigwell P, Johnson M (1998) The nature of fatigue in multiple sclerosis. J Psychosom Res 45(1):33–38
Trojan DA, Arnold D, Collet JP, Shapiro S, Bar-Or A, Robinson A et al (2007) Fatigue in multiple sclerosis: association with disease-related, behavioural and psychosocial factors. Mult Scler 13(8):985–995
Funding
None.
Author information
Authors and Affiliations
Contributions
SB: conceptualization, data curation, formal analysis, investigation, methodology, project administration, software, validation, visualization, writing—original draft, writing—review & editing. JPL: data curation, investigation, software, visualization. BD: project administration, resources, supervision, validation, visualization, writing—review & editing.
Corresponding author
Ethics declarations
Conflicts of interest
Authors have nothing to declare.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
For this type of study formal consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Borrelli, S., Pereira Lima, J. & Dachy, B. The relation between the symbol digit modalities test, fatigue, depression, and anxiety symptoms in a Belgian MS cohort. Acta Neurol Belg 123, 2147–2153 (2023). https://doi.org/10.1007/s13760-022-02127-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-022-02127-4